Drug information for APOKYN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; SUBCUTANEOUS
20MG/2ML (10MG/ML)
Discontinued
APOMORPHINE HYDROCHLORIDE
Apomorphine
US WORLDMEDS
21264
2010-09-07 Letter
2010-09-07 Label
2009-01-06 Letter
2009-01-06 Letter
2004-08-27 Review
2004-05-04 Label
2004-04-29 Letter
INJECTABLE; SUBCUTANEOUS
30MG/3ML (10MG/ML)
Prescription
(Reference Drug)
APOMORPHINE HYDROCHLORIDE
Apomorphine
US WORLDMEDS
"
Drug Adverse Effects information for APOKYN
Role code
Indications
Reaction
# Reports
PS
PARKINSON'S DISEASE
CARDIAC DISORDER
1
PS
PARKINSON'S DISEASE
COMPUTERISED TOMOGRAM ABNORMAL
1
PS
PARKINSON'S DISEASE
CONDITION AGGRAVATED
1
PS
PARKINSON'S DISEASE
CONTUSION
1
PS
PARKINSON'S DISEASE
COOMBS TEST POSITIVE
1
PS
PARKINSON'S DISEASE
FALL
1
PS
PARKINSON'S DISEASE
HEPATIC INFECTION BACTERIAL
1
PS
PARKINSON'S DISEASE
LIVER ABSCESS
1
PS
PARKINSON'S DISEASE
MALAISE
1
Ads by Google